The Effect of Body Fat Tissue Distribution in Obese and Premenopausal Patients Complicated with Endometrial Hyperplasia

Objective: There is a close association between obesity and menstrual irregularity.This study is aimed to investigate lipoid tissue accumulation between overweight or obese premenopausal patients with endometrial hyperplasia and overweight or obese volunteers with benign pathologic lesions via using bioimpedance method. Materyal and methods: Obese or overweight volunteers with abnormal uterine bleeding were examined.88 volunteers meet inclusion criteria.We obtained fat mass, fat percentage and impedance of body parts by using Multi-Frequency Body Composition Analyzer.Blood lipid profile and ultrasonographic measurement of endometrial thickness were performed for all volunteers. Results:33 volunteers were in the hyperplasia group and 55 were in the control group. 28 of the 33 volunteers (84.8 %) had at least one increased fatty acids in endometrial hyperplasia group. 41 of the 55 patients (74.5 %) had at least one increased fatty acids in control group. Total cholesterol levels are higher in the hyperplasia group than the control group (p=0,006). There was no significant difference between hyperplasia and control group for bioimpedance analyses. Conclusion:Hyperlipidemia remains an important factor that contributes endometrial pathologies. Serum cholesterols were significantly high in endometrial hyperplasia group. Rather than lipoid tissue distribution, increased cholesterol may contribute gynecologic pathology occurrence in obese individuals complicated with endometrial hyperplasia.

[1]  M. Blüher Metabolically Healthy Obesity , 2020, Endocrine reviews.

[2]  B. Korczowski,et al.  The Relationship between Body Composition and Muscle Tone in Children with Cerebral Palsy: A Case-Control Study , 2020, Nutrients.

[3]  L. Insabato,et al.  Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment , 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[4]  Luca Giannella,et al.  Prediction of Endometrial Hyperplasia and Cancer among Premenopausal Women with Abnormal Uterine Bleeding , 2019, BioMed research international.

[5]  L. Ellegård,et al.  Body composition in patients with primary neuromuscular disease assessed by dual energy X-ray absorptiometry (DXA) and three different bioimpedance devices. , 2019, Clinical nutrition ESPEN.

[6]  S. Kaya,et al.  Is there any relationship between benign endometrial pathologies and metabolic status? , 2018, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[7]  T. Yuen,et al.  FSH, Bone Mass, Body Fat, and Biological Aging. , 2018, Endocrinology.

[8]  B. Dilbaz,et al.  Impact of obesity on infertility in women. , 2015, Journal of the Turkish German Gynecological Association.

[9]  M. Beckmann,et al.  New WHO Classification of Endometrial Hyperplasias. , 2015, Geburtshilfe und Frauenheilkunde.

[10]  Yong Xu,et al.  Central Leptin Regulation of Obesity and Fertility , 2012, Current Obesity Reports.

[11]  C. Matthews,et al.  Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. , 2005, American journal of epidemiology.